These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9322345)

  • 1. The treatment of febrile neutropenia: from the Dark Ages to the present.
    Bodey GP
    Support Care Cancer; 1997 Sep; 5(5):351-7. PubMed ID: 9322345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of neutropenic infection: trends towards monotherapy?
    Klastersky J
    Support Care Cancer; 1997 Sep; 5(5):365-70. PubMed ID: 9322347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient management of the febrile neutropenic child with cancer.
    Patrick CC; Shenep JL
    Adv Pediatr Infect Dis; 1999; 14():29-47. PubMed ID: 10079848
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
    Vidal L; Paul M; Ben dor I; Soares-Weiser K; Leibovici L
    J Antimicrob Chemother; 2004 Jul; 54(1):29-37. PubMed ID: 15201227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting the results of randomized trials of empiric antibiotics in febrile neutropenic patients--a critical survey.
    Pater JL; Weir L
    J Clin Oncol; 1986 Mar; 4(3):346-52. PubMed ID: 3512784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
    Marie-Cardine A; Schneider P; Blot N; Tron P; Vannier JP
    Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2nd International Symposium on Febrile Neutropenia, Brussels, 14-16 December 1995.
    Hess U
    Support Care Cancer; 1996 Jul; 4(4):320-1. PubMed ID: 8829314
    [No Abstract]   [Full Text] [Related]  

  • 9. [Febrile neutropenia in adult patients with solid tumours: a review of literature toward a rational and optimal management].
    Even C; Taillade L; Spano JP; Vignot S
    Bull Cancer; 2010 May; 97(5):547-57. PubMed ID: 20176547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outpatient antibiotic treatment in low-risk febrile neutropenic cancer patients.
    Escalante CP; Rubenstein EB; Rolston KV
    Support Care Cancer; 1996 Sep; 4(5):358-63. PubMed ID: 8883229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
    Montalar J; Segura A; Bosch C; Galan A; Juan O; Molins C; Giner V; Aparicio J
    Med Oncol; 2002; 19(3):161-6. PubMed ID: 12482126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is monotherapy for febrile neutropenia still a viable alternative?
    Ramphal R
    Clin Infect Dis; 1999 Sep; 29(3):508-14. PubMed ID: 10530437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
    Malik I; Hussain M; Yousuf H
    J Infect; 2001 Feb; 42(2):120-5. PubMed ID: 11531318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients].
    Robinson JO; Calandra T; Marchetti O
    Rev Med Suisse; 2005 Mar; 1(13):878-82, 885-6. PubMed ID: 15895930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and pharmacodynamics of antibacterial agents: on account of febrile neutropenic patients].
    Garzón JR; Cuervo M S; Gómez R J; Cortés JA
    Rev Chilena Infectol; 2011 Dec; 28(6):537-45. PubMed ID: 22286676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Admission and care of the febrile neutropenic patient in a community hospital setting.
    Ford MS; Helsley M
    J Support Oncol; 2005; 3(6 Suppl 4):22-3. PubMed ID: 16355555
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging bacterial resistance patterns in febrile neutropenic patients: experience at a tertiary care hospital in Pakistan.
    Khan MA; Siddiqui BK; Shamim A; Yosuf MA; Ahmed U; Zakiullah N; Burney IA
    J Pak Med Assoc; 2004 Jul; 54(7):357-60. PubMed ID: 15449917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations.
    de Lalla F
    Drugs; 1997 May; 53(5):789-804. PubMed ID: 9129866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
    Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H
    J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febrile neutropenia in cancer patients in Kuwait: microbial spectrum and outcome.
    al-Bahar S; Pandita R; Dhabhar BN; al-Bahar E
    Support Care Cancer; 1994 Nov; 2(6):400-2. PubMed ID: 7858935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.